
European markets edged higher on news that a third dose of the Covid-19 vaccine produced by Pfizer and German partner BioNTech could fend off the Omicron variant. US stocks too rose but gave up a portion of their early gains. At home, the perception of risk in the market abated further, with the Volatility Index (VIX) declining 6.5% to 17.27.
from Markets-Economic Times https://ift.tt/3EHhr0C
Post a Comment